YOSHIO YAMAOKA to High-Throughput Nucleotide Sequencing
This is a "connection" page, showing publications YOSHIO YAMAOKA has written about High-Throughput Nucleotide Sequencing.
Connection Strength
0.715
-
Helicobacter pylori Pathogenic Factors and Their Interactions With the Gastric Microbiome. Helicobacter. 2025 Sep-Oct; 30(5):e70072.
Score: 0.157
-
Identification of genetic determinants of antibiotic resistance in Helicobacter pylori isolates in Vietnam by high-throughput sequencing. BMC Microbiol. 2025 May 02; 25(1):264.
Score: 0.154
-
Two populations of less-virulent Helicobacter pylori genotypes in Bangladesh. PLoS One. 2017; 12(8):e0182947.
Score: 0.090
-
Emerging Helicobacter pylori levofloxacin resistance and novel genetic mutation in Nepal. BMC Microbiol. 2016 11 04; 16(1):256.
Score: 0.085
-
Search for novel candidate mutations for metronidazole resistance in Helicobacter pylori using next-generation sequencing. Antimicrob Agents Chemother. 2015 Apr; 59(4):2343-8.
Score: 0.076
-
Discovery of novel mutations for clarithromycin resistance in Helicobacter pylori by using next-generation sequencing. J Antimicrob Chemother. 2014 Jul; 69(7):1796-803.
Score: 0.071
-
Molecular epidemiology, population genetics, and pathogenic role of Helicobacter pylori. Infect Genet Evol. 2012 Mar; 12(2):203-13.
Score: 0.061
-
Clarithromycin-Based Triple Therapy is Still Useful as an Initial Treatment for Helicobacter pylori Infection in the Dominican Republic. Am J Trop Med Hyg. 2017 May; 96(5):1050-1059.
Score: 0.022